A Personal COVID Vaccine Experience

We were doing our part to help facilitate making the vaccine available to the public.

I was feeling confined and socially distanced due to COVID-19, as many of us are – and anxious for a vaccine so I could get back to a more normal life. I had heard about vaccine trials on the national news, so I did some research on the Internet about them. The closest clinical trials were 70 miles from where I live. My husband encouraged me to get more information, so I called the clinical trial phone number, and they sent us paperwork to complete.

We felt that enrolling in a trial would help facilitate the process of making a vaccine available to the public. We knew participants for clinical trials were needed. I also was hoping to get a vaccine as soon as possible. We began this process in September, when Moderna and Pfizer were in third-phase clinical trials. We were both eligible, and it was determined by the research center in Jacksonville, Florida that we would be in the Pfizer trial, as we were adhering to the Centers for Disease Control and Prevention (CDC) recommendations for social distancing and wearing masks.

We had an initial phone interview and were sent forms via email. We completed a medical history form and current medication list, and signed a consent. We had a phone interview during which I asked several questions, including “what happens if we get placebo?”, “when can we get the actual vaccines?”, “if the Pfizer vaccine is not approved, can we get an approved vaccine when one becomes available?”, and “how long will the trial last?” We were given information about our commitment, which is two years, and were accepted into the Pfizer clinical trial.

In early October, I drove to Jacksonville, where I met with the staff at the clinical research center. I was interviewed by a staff member, had vital signs taken, and received a brief physical by a physician. I signed a lengthy consent form, had a COVID test, and received my first injection in the beginning of October. My husband received his a week later. We were given a kit with a thermometer, a COVID test, instructions for an app to keep a weekly diary, and contact information in case we developed COVID symptoms..

I received the second injection three weeks later, and had at least two subsequent appointments for follow-up physicals, additional COVID tests, labs, and interviews. My husband had similar visits, and one additional visit after he had one possible vague COVID symptom, which he reported. When this happened, he called the research center, and he was instructed to do a COVID test. I was positive he didn’t have COVID, but we followed protocol.

When I received the two injections, I did not have any symptoms, while my husband had dizziness for a few days, which was worse after the second injection. This led me to believe that I likely had received the placebo, and he had received the actual vaccine. This study was blinded, and we were unable to verify this. The staff thought we might be a priority for the vaccine if we received the placebo when I inquired, but we did not have this in writing, as it was not confirmed.

When the vaccine was approved for emergency use and nurses were able to be vaccinated in Georgia, I called the research center to inquire if I received the vaccine or placebo. The vaccine was available where I worked, and I was anxious to have this information. About two weeks later and after several calls, my case was unblinded, I determined I had not received the vaccine, and then I was given an appointment to receive one on Dec. 22. It was a great Christmas present!

My husband’s study was to be blinded until his next appointment, but that later changed. We recently learned that he did get the Pfizer vaccine in October!

Most of our follow-up at this point will be via phone, and we continue to complete our weekly diaries. When we have spoken to friends, some people are interested in our experience and appreciative for our efforts, and others joke about us being guinea pigs. We feel we were only trying to do our part to help facilitate making the vaccine available to the public.

Programming Note: Listen to Carol Lester report this story live today during Talk Ten Tuesdays, 10 a.m. Eastern.

Facebook
Twitter
LinkedIn

Related Stories

Leave a Reply

Please log in to your account to comment on this article.

Featured Webcasts

The Cost of Ignoring Risk Adjustment: How HCCs Impact Revenue & Compliance

The Cost of Ignoring Risk Adjustment: How HCCs Impact Revenue & Compliance

Stop revenue leakage and boost hospital performance by mastering risk adjustment and HCCs. This essential webcast with expert Cheryl Ericson, RN, MS, CCDS, CDIP, will reveal how inaccurate patient acuity documentation leads to lost reimbursements through penalties from poor quality scores. Learn the critical differences between HCCs and traditional CCs/MCCs, adapt your CDI workflows, and ensure accurate payments in Medicare Advantage and value-based care models. Perfect for HIM leaders, coders, and CDI professionals.  Don’t miss this chance to protect your hospital’s revenue and reputation!

May 29, 2025
I050825

Mastering ICD-10-CM Coding for Diabetes and it’s Complications: Avoiding Denials & Ensuring Compliance

Struggling with ICD-10-CM coding for diabetes and complications? This expert-led webcast clarifies complex combination codes, documentation gaps, and sequencing rules to reduce denials and ensure compliance. Dr. Angela Comfort will provide actionable strategies to accurately link diabetes to complications, improve provider documentation, and optimize reimbursement—helping coders, CDI specialists, and HIM leaders minimize audit risks and strengthen revenue integrity. Don’t miss this chance to master diabetes coding with real-world case studies, key takeaways, and live Q&A!

May 8, 2025
2025 Coding Clinic Webcast Series

2025 ICD-10-CM/PCS Coding Clinic Update Webcast Series

Uncover critical guidance. HIM coding expert, Kay Piper, RHIA, CDIP, CCS, provides an interactive review on important information in each of the AHA’s 2025 ICD-10-CM/PCS Quarterly Coding Clinics in easy-to-access on-demand webcasts, available shortly after each official publication.

April 14, 2025

Trending News

Featured Webcasts

The Two-Midnight Rule: New Challenges, Proven Strategies

The Two-Midnight Rule: New Challenges, Proven Strategies

RACmonitor is proud to welcome back Dr. Ronald Hirsch, one of his most requested webcasts. In this highly anticipated session, Dr. Hirsch will break down the complex Two Midnight Rule Medicare regulations, translating them into clear, actionable guidance. He’ll walk you through the basics of the rule, offer expert interpretation, and apply the rule to real-world clinical scenarios—so you leave with greater clarity, confidence, and the tools to ensure compliance.

June 19, 2025
Open Door Forum Webcast Series

Open Door Forum Webcast Series

Bring your questions and join the conversation during this open forum series, live every Wednesday at 10 a.m. EST from June 11–July 30. Hosted by Chuck Buck, these fast-paced 30-minute sessions connect you directly with top healthcare experts tackling today’s most urgent compliance and policy issues.

June 11, 2025
Open Door Forum: The Changing Face of Addiction: Coding, Compliance & Care

Open Door Forum: The Changing Face of Addiction: Coding, Compliance & Care

Substance abuse is everywhere. It’s a complicated diagnosis with wide-ranging implications well beyond acute care. The face of addiction continues to change so it’s important to remember not just the addict but the spectrum of extended victims and the other social determinants and legal ramifications. Join John K. Hall, MD, JD, MBA, FCLM, FRCPC, for a critical Q&A on navigating substance abuse in 2025.  Register today and be a part of the conversation!

July 16, 2025

Trending News

Prepare for the 2025 CMS IPPS Final Rule with ICD10monitor’s IPPSPalooza! Click HERE to learn more

Get 15% OFF on all educational webcasts at ICD10monitor with code JULYFOURTH24 until July 4, 2024—start learning today!

CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24